πŸš€ VC round data is live in beta, check it out!

Alpha Tau Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Alpha Tau Medical and similar public comparables like Bioventus, Synektik, Sunmax Biotechnology, MedicalSystem Technology and more.

Alpha Tau Medical Overview

About Alpha Tau Medical

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation’s limited range. The company derives maximum revenue from Israel.


Founded

2015

HQ

Israel

Employees

125

Financials (LTM)

Revenue: $381K
EBITDA: ($44M)

EV

$650M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Alpha Tau Medical Financials

Alpha Tau Medical reported last 12-month revenue of $381K and negative EBITDA of ($44M).

In the same LTM period, Alpha Tau Medical generated $89K in gross profit, ($44M) in EBITDA losses, and had net loss of ($44M).

Revenue (LTM)


Alpha Tau Medical P&L

In the most recent fiscal year, Alpha Tau Medical reported revenue of β€” and EBITDA of ($41M).

Alpha Tau Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Alpha Tau Medical forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$381KXXXβ€”XXXXXXXXX
Gross Profit$89KXXXβ€”XXXXXXXXX
Gross Margin23%XXXβ€”XXXXXXXXX
EBITDA($44M)XXX($41M)XXXXXXXXX
EBITDA Margin(11594%)XXXβ€”XXXXXXXXX
EBIT Margin(11631%)XXXβ€”XXXXXXXXX
Net Profit($44M)XXX($43M)XXXXXXXXX
Net Margin(11457%)XXXβ€”XXXXXXXXX

Financial data powered by Morningstar, Inc.

Alpha Tau Medical Stock Performance

Alpha Tau Medical has current market cap of $709M, and enterprise value of $650M.

Market Cap Evolution


Alpha Tau Medical's stock price is $8.06.

See Alpha Tau Medical trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$650M$709M0.0%XXXXXXXXX$-0.48

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Alpha Tau Medical Valuation Multiples

Alpha Tau Medical trades at 1707.0x EV/Revenue multiple, and (14.7x) EV/EBITDA.

See valuation multiples for Alpha Tau Medical and 15K+ public comps

EV / Revenue (LTM)


Alpha Tau Medical Financial Valuation Multiples

As of April 19, 2026, Alpha Tau Medical has market cap of $709M and EV of $650M.

Equity research analysts estimate Alpha Tau Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Alpha Tau Medical has a P/E ratio of (16.3x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$709MXXX$709MXXXXXXXXX
EV (current)$650MXXX$650MXXXXXXXXX
EV/Revenue1707.0xXXXβ€”XXXXXXXXX
EV/EBITDA(14.7x)XXX(15.9x)XXXXXXXXX
EV/EBIT(14.7x)XXX(15.4x)XXXXXXXXX
EV/Gross Profit7340.5xXXXβ€”XXXXXXXXX
P/E(16.3x)XXX(16.6x)XXXXXXXXX
EV/FCFβ€”XXX(19.8x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Alpha Tau Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Alpha Tau Medical Margins & Growth Rates

Alpha Tau Medical's revenue in the last 12 month grew by 1430%.

Alpha Tau Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.

See operational valuation multiples for Alpha Tau Medical and other 15K+ public comps

Alpha Tau Medical Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth1430%XXXβ€”XXXXXXXXX
EBITDA Margin(11594%)XXXβ€”XXXXXXXXX
EBITDA Growth11%XXX26%XXXXXXXXX
Revenue per Employeeβ€”XXX$0.0MXXXXXXXXX
Opex per Employeeβ€”XXX$0.3MXXXXXXXXX
S&M Expenses to Revenue506%XXXβ€”XXXXXXXXX
G&A Expenses to Revenue2297%XXXβ€”XXXXXXXXX
R&D Expenses to Revenue8826%XXXβ€”XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Alpha Tau Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Alpha Tau MedicalXXXXXXXXXXXXXXXXXX
BioventusXXXXXXXXXXXXXXXXXX
SynektikXXXXXXXXXXXXXXXXXX
Sunmax BiotechnologyXXXXXXXXXXXXXXXXXX
MedicalSystem TechnologyXXXXXXXXXXXXXXXXXX
SD BiosensorXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Alpha Tau Medical M&A Activity

Alpha Tau Medical acquired XXX companies to date.

Last acquisition by Alpha Tau Medical was on XXXXXXXX, XXXXX. Alpha Tau Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Alpha Tau Medical

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Alpha Tau Medical Investment Activity

Alpha Tau Medical invested in XXX companies to date.

Alpha Tau Medical made its latest investment on XXXXXXXX, XXXXX. Alpha Tau Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Alpha Tau Medical

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Alpha Tau Medical

When was Alpha Tau Medical founded?Alpha Tau Medical was founded in 2015.
Where is Alpha Tau Medical headquartered?Alpha Tau Medical is headquartered in Israel.
How many employees does Alpha Tau Medical have?As of today, Alpha Tau Medical has over 125 employees.
Who is the CEO of Alpha Tau Medical?Alpha Tau Medical's CEO is Uzi Sofer.
Is Alpha Tau Medical publicly listed?Yes, Alpha Tau Medical is a public company listed on Nasdaq.
What is the stock symbol of Alpha Tau Medical?Alpha Tau Medical trades under DRTS ticker.
When did Alpha Tau Medical go public?Alpha Tau Medical went public in 2022.
Who are competitors of Alpha Tau Medical?Alpha Tau Medical main competitors are Bioventus, Synektik, Sunmax Biotechnology, MedicalSystem Technology.
What is the current market cap of Alpha Tau Medical?Alpha Tau Medical's current market cap is $709M.
What is the current revenue of Alpha Tau Medical?Alpha Tau Medical's last 12 months revenue is $381K.
What is the current revenue growth of Alpha Tau Medical?Alpha Tau Medical revenue growth (NTM/LTM) is 1430%.
What is the current EV/Revenue multiple of Alpha Tau Medical?Current revenue multiple of Alpha Tau Medical is 1707.0x.
Is Alpha Tau Medical profitable?No, Alpha Tau Medical is not profitable.
What is the current EBITDA of Alpha Tau Medical?Alpha Tau Medical has negative EBITDA and is not profitable.
What is Alpha Tau Medical's EBITDA margin?Alpha Tau Medical's last 12 months EBITDA margin is (11594%).
What is the current EV/EBITDA multiple of Alpha Tau Medical?Current EBITDA multiple of Alpha Tau Medical is (14.7x).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial